Highlights from this issue
Whose risk is it anyway?
SKUP3
Eight o'clock ROCK!
Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2)
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
Reduced pH in the airways alters bacterial killing in CFTR−/− porcine lungs
Early mortality after surgical resection for lung cancer
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
SKUP3 randomised controlled trial
The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal
Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease
Correction
Provision of home mechanical ventilation and sleep services for England survey
Indwelling pleural catheters versus chest tube and talc pleurodesis in malignant pleural effusion
Number needed to treat in COPD
Author's response to letter on number needed to treat in COPD
Idiopathic pulmonary fibrosis or not
Another aspect-oriented approach to diagnosis of cardiac amyloidosis
Author's response
Retraction
Commentary
Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shunt
The Emperor's New Clothes II—time for regulators to wake up and take responsibility for unnecessary asthma morbidity
A risk model for lung cancer screening
Life-threatening haemoptysis due to tracheal varices secondary to pulmonary vein obstruction
Mycobacterium tuberculosis DNA facilitates selective autophagy within infected macrophages
What's hot that the other lot got